Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APD421 for Prevention of PONV
NCT01510704Phase 2Completed
- Sponsor
- Acacia Pharma Group Plc
- Start
- Jan 2012
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of amisulpride in postoperative nausea and vomiting (PONV), sponsored by Acacia Pharma Group Plc. Started Jan 2012; status: completed.
02
Drugs
amisulpride
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT01510704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01510704.